Immunology & Oncology Showreel 2020

Jun 18, 2020 | Projects

This showreel is a selection of some of our 3D medical animation work focused on the oncology and immunology field.

Through medical animation we take you on an immersive journey, exploring the biological processes involved in the development of cancer.

3D medical immunology field

Understanding the Mechanisms of Disease (MoD) involved in cancer is essential to acknowledge how we can target tumors. We help you visualize the MoD in cancer, and how cutting-edge treatments can be used to overcome this condition. We achieved this through the visual explanation of the mechanism of action (MoA) of oncology therapies.

Numerous laboratories and biotech companies have put in our hands the development of these 3D animation videos to explain the mechanism of action of their therapies and technologies, including Rakuten Medical.

Rakuten Medical develops pioneering new approaches to treat cancer by combining the targeting power of antibodies with laser-activated precision.

Showreel of Immunology and Oncology field

Rakuten Medical’s lead investigational product ASP-1929 is an antibody-drug conjugate of cetuximab and IRDye 700DX®. ASP-1929 targets epidermal growth factor (EGFR), which is expressed in multiple types of solid tumors, including head and neck squamous cell carcinomas, esophageal cancer, lung cancer, colorectal cancer, pancreatic cancer, and other cancers. After the antibody binds to the tumor, ASP-1929 is locally activated with red light using a proprietary investigational laser and fiber optics.

3D medical Oncology field

3DforScience visualized the technology of Rakuten through a cutting-edge 3D animation video, and thus, explained the mechanism of action of Rakuten’s technology in a clear, engaging, and concise way, adding value to such technology.

Among other companies, we have had the pleasure to work for N4 Pharma, a pharmaceutical company specialized in the development of a novel silica nanoparticle delivery system for vaccines and therapeutics.

We have also worked with Imcyse, for which we produced a medical animation video to explain a new class immunotherapeutic molecule: Imotopes.

In addition, we have produced animations for  Hybrigenics Pharma, a biopharmaceutical company focused on the development of new therapies against proliferative diseases, such as chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML) and acute myeloid leukemia (AML), among others.

Medical oncology therapies

How can 3DforScience help you?

3DforScience is a scientific communication company specialized in digital content for the pharma and biotech industries. Our passionate creative team works alongside an in-house scientific team to provide cutting-edge medical animations, scientific illustrations, virtual reality, etc.

Our extensive experience within the field ensures all the content we produce is scientifically accurate, innovative, engaging, and pitched at the right level for the target audience. Would you like to bring your scientific messaging to life? Contact us. We would love to help you create something unique.


Related news

High performance sustainable material: Sappi Symbio

High performance sustainable material: Sappi Symbio

Sappi is a global company focused on providing dissolving pulp, paper pulp, paper-based and biorefinery solutions to its customers in over 150 countries. They invest in research and development programs, unlocking the true potential of sustainable renewable resources,...

cPass™ technology by GenScript

cPass™ technology by GenScript

Coronaviruses are a large family of viruses that may cause illness in animals or humans.  In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS)...

B2B device: from breast to bone

B2B device: from breast to bone

ABOUT CLIENT: B2B is an EU-funded project that aims to develop a breakthrough technology that for the first time dissects the steps of spontaneous breast cancer metastasis to the bone and captures the 3D complexity of the process. The project started in July 2018,...